Garrison Bradford & Associates’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-253
| Closed | -$9K | – | 85 |
|
|
2018
Q4 | $9K | Sell |
253
-770
| -75% | -$27.4K | 0.01% | 79 |
|
|
2018
Q3 | $76K | Sell |
1,023
-105
| -9% | -$7.8K | 0.06% | 75 |
|
|
2018
Q2 | $88K | Sell |
1,128
-78
| -6% | -$6.09K | 0.07% | 79 |
|
|
2018
Q1 | $106K | Sell |
1,206
-20
| -2% | -$1.76K | 0.09% | 75 |
|
|
2017
Q4 | $912K | Sell |
1,226
-18
| -1% | -$13.4K | 0.75% | 22 |
|
|
2017
Q3 | $358K | Buy |
1,244
+1,030
| +481% | +$296K | 0.3% | 50 |
|
|
2017
Q2 | $55K | Buy |
214
+25
| +13% | +$6.43K | 0.05% | 82 |
|
|
2017
Q1 | $63K | Hold |
189
| – | – | 0.06% | 81 |
|
|
2016
Q4 | $114K | Sell |
189
-24
| -11% | -$14.5K | 0.11% | 77 |
|
|
2016
Q3 | $241K | Sell |
213
-13
| -6% | -$14.7K | 0.23% | 63 |
|
|
2016
Q2 | $247K | Sell |
226
-2
| -0.9% | -$2.19K | 0.24% | 63 |
|
|
2016
Q1 | $293K | Buy |
228
+2
| +0.9% | +$2.57K | 0.34% | 49 |
|
|
2015
Q4 | $555K | Sell |
226
-8
| -3% | -$19.6K | 0.62% | 36 |
|
|
2015
Q3 | $258K | Buy |
234
+20
| +9% | +$22.1K | 0.28% | 63 |
|
|
2015
Q2 | $214K | Hold |
214
| – | – | 0.21% | 78 |
|
|
2015
Q1 | $217K | Hold |
214
| – | – | 0.2% | 81 |
|
|
2014
Q4 | $712K | Buy |
214
+8
| +4% | +$26.6K | 0.65% | 35 |
|
|
2014
Q3 | $597K | Sell |
206
-6
| -3% | -$17.4K | 0.6% | 38 |
|
|
2014
Q2 | $805K | Buy |
+212
| New | +$805K | 0.75% | 32 |
|